iVEAcare

Minneapolis, United States

iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.

$27.5M raised

Apr 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has iVEAcare raised?

iVEAcare has raised $27.5M in total funding. The most recent round was Series A. The last funding was announced in April 2024.

Who are iVEAcare's investors?

iVEAcare's investors include Hatteras Venture Partners, Vensana Capital, Treo Ventures.

Where is iVEAcare headquartered?

iVEAcare is headquartered in Minneapolis, United States.

What does iVEAcare do?

iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.

What stage is iVEAcare at?

iVEAcare is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 22, 2024.

MLA

"iVEAcare — Funding & Investors." VCBacked, April 22, 2024, https://www.vcbacked.co/company/iveacare. Accessed July 3, 2026.

APA

VCBacked. (2024). iVEAcare — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/iveacare

Wikipedia (cite web)

{{cite web |title=iVEAcare — Funding & Investors |url=https://www.vcbacked.co/company/iveacare |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 22, 2024.